Quick Answer
Galmed Pharmaceuticals Ltd. reported Shares Outstanding of 6.58 million shares for fiscal year 2025.
Galmed Pharmaceuticals Ltd. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 6.58M | +295.3% |
| 2024 | 1.66M | +190.2% |
| 2023 | 573,741 | -66.1% |
| 2022 | 1.69M | -93.3% |
| 2021 | 25.09M | +17.6% |
| 2020 | 21.33M | +0.9% |
| 2019 | 21.14M | +0.6% |
| 2018 | 21.02M | +45.6% |
| 2017 | 14.44M | +18.8% |
| 2016 | 12.15M | +9.4% |
| 2015 | 11.10M | +0.0% |
| 2014 | 11.10M | +113879.4% |
| 2013 | 9,739 | — |
- Galmed Pharmaceuticals Ltd. showed an increase of +295.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Galmed Pharmaceuticals Ltd.’s shares outstanding has grown by 67477.7% (from 9.7 thousand shares to 6.58 million shares).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: